Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Total Brain Limited
  6. News
  7. Summary
    TTB   AU0000032435

TOTAL BRAIN LIMITED

(TTB)
  Report
Delayed Australian Stock Exchange  -  08:08 2022-09-28 pm EDT
0.0470 AUD   +4.44%
08/30Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/05Total Brain Agrees to Salell Business for $10 Million
MT
08/05SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for $10 million.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Total Brain Licenses Ispot-D for Depression Research

12/21/2021 | 06:19am EDT

Total Brain Limited announced that the company will license its International Study to Predict Optimized Treatment for Depression research data to Janssen Research & Development, LLC. The company will use Total Brain's iSPOT-D data to support clinical studies and precision drug development efforts to treat depression. This perpetual license agreement is non-exclusive and makes Janssen R&D the third company to license the iSPOT-D data. iSPOT-D is the study of its kind in depression. The study identified objective indicators of treatment response in more than 1,700 depressed individuals using genetics, cognition, brain structure and function imaging, as well as a range of clinical measures, including: Genetics (850,000 SNPs) A battery of cognitive tests Electroencephalogram (EEG) Event related potentials (ERP) Magnetic resonance imaging (MRI) Diffusion tensor imaging (DTI) Functional magnetic resonance imaging (FMRI) Mainstream clinical assessments.


© S&P Capital IQ 2021
All news about TOTAL BRAIN LIMITED
08/30Total Brain Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/05Total Brain Agrees to Salell Business for $10 Million
MT
08/05SonderMind Inc. entered into an agreement to acquire Assets of Total Brain Limited for ..
CI
06/02Total Brain : Application for quotation of securities - TTB
PU
06/02Total Brain Limited announced that it expects to receive AUD 0.0396 million in funding
CI
05/26VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to ..
CI
05/20Total Brain : Dr. Evian Gordon, Chief Medical Officer, Total Brain, to Address the Role of..
PU
05/10Total Brain Limited Announces 5-Year Extension of AARP Contract
CI
05/03Transcript : Total Brain Limited, Q3 2022 Earnings Call, May 04, 2022
CI
04/10Total Brain : Notification regarding unquoted securities - TTB
PU
More news
Financials
Sales 2022 9,80 M 6,35 M 6,35 M
Net income 2022 -4,00 M -2,59 M -2,59 M
Net Debt 2022 2,36 M 1,53 M 1,53 M
P/E ratio 2022 -1,64x
Yield 2022 -
Capitalization 6,28 M 4,07 M 4,07 M
EV / Sales 2022 0,88x
EV / Sales 2023 0,60x
Nbr of Employees 29
Free-Float 59,3%
Chart TOTAL BRAIN LIMITED
Duration : Period :
Total Brain Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TOTAL BRAIN LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,05
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Matthew Mund Chief Executive & Operating Officer
Evian Gordon Executive Chairman & Chief Medical Officer
Donna Palmer Chief Science Officer
Matthew Morgan Non-Executive Director
David Torrible Non-Executive Director